Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 2/20 | 0.42 |
| ▸ | CSNK1E | P49674 | 1/20 | 0.42 |
| ▸ | CTSK | P43235 | 6/20 | 0.40 |
| ▸ | CTSL | P07711 | 3/20 | 0.40 |
| ▸ | CTSB | P07858 | 3/20 | 0.40 |
| ▸ | CTSH | P09668 | 2/20 | 0.40 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | MME | P08473 | 1/20 | 0.37 |
| ▸ | ACE | P12821 | 1/20 | 0.37 |
| ▸ | CPA1 | P15085 | 1/20 | 0.37 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.37 |
| ▸ | PTGES | O14684 | 1/20 | 0.36 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
| ▸ | PPARG | P37231 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28173909 | 0.87 | MME (0.41) | CNR2CTSKCTSLCTSBMME | |
| SCHEMBL15479086 | 0.86 | CYP1A2 (0.42) | SIGMAR1CPA1 | |
| SCHEMBL23123157 | 0.84 | SIGMAR1 (0.43) | SIGMAR1 | |
| SCHEMBL28103077 | 0.78 | CYP1A2 (0.36) | SIGMAR1MMECPA1 | |
| SCHEMBL27888074 | 0.78 | CA2 (0.35) | SMN1; SMN2 | |
| SCHEMBL27400575 | 0.77 | TRPA1 (0.44) | CPA1 | |
| SCHEMBL6441532 | 0.77 | CSNK1E (0.53) | CNR2CSNK1E | |
| SCHEMBL6443017 | 0.77 | CSNK1E (0.53) | CNR2CSNK1E | |
| SCHEMBL693020 | 0.76 | CYP1A2 (0.37) | SIGMAR1MMECPA1 | |
| SCHEMBL7300322 | 0.76 | CNR2 (0.44) | CNR2CSNK1ECTSKCTSLCTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1328550-A | Oxazole compounds as prostaglandin E2 agonists or antagonists | FUJISAWA PHARMACEUTICAL CO (JP) | 2001-12-26 | — | — | CN | disclosed |